Elevating Liver Disease Globally: How do we get there?

Description

This is a healthy liver, healthy lives (HLHL) symposium bringing the global community together to elevate liver disease as a global health priority.

Presentations

9:45 AM - 9:47 AM
Nov 09 2025
Washington, D.C.

Welcome

Grace Su, MD, FAASLD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Hepatitis
Liver Cancer
MASLD
9:47 AM - 9:57 AM
Nov 09 2025
Washington, D.C.

Global Liver Disease - Tip of the Iceberg

Oren K Fix, MD, MSc, FAASLD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Hepatitis
Liver Cancer
MASLD
9:57 AM - 10:07 AM
Nov 09 2025
Washington, D.C.

Making Liver Disease Relevant to a Global Audience/Non-hepatologist Audience

Melina I Manolas, MD, MPH, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Hepatitis
Liver Cancer
MASLD
10:07 AM - 10:42 AM
Nov 09 2025
Washington, D.C.

Panel Discussion

Tamar H Taddei, MD, MD, FAASLD, Moderator
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Hepatitis
Liver Cancer
MASLD
10:42 AM - 10:45 AM
Nov 09 2025
Washington, D.C.

Closing

Mazen Noureddin, MD, MHSc, Moderator
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Hepatitis
Liver Cancer
MASLD

Objectives

  • At the end of this session, attendees will be able to describe the global burden of liver disease and explain why it is underdiagnosed.
  • Attendees will be able to describe ways that liver disease could be elevated as a priority with a non-hepatologist audience, including primary care providers.
  • Discuss ways hepatology providers can facilitate the early recognition of liver disease in the community.